Related Experiment Video
Updated: Dec 17, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Imaging biomarkers of diffuse liver disease: current status
Bachir Taouli1,2, Filipe Caseiro Alves3
1Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine At Mount Sinai, 1470 Madison Avenue, New York, NY, 10029, USA. bachir.taouli@mountsinai.org.
This special issue explores diffuse liver disease imaging. Experts discuss ultrasound, CT, MRI, and molecular agents, highlighting current status, limitations, and future directions for imaging biomarkers.
Area of Science:
- Radiology
- Medical Imaging
- Hepatology
Background:
- Diffuse liver diseases encompass a range of conditions affecting the entire liver parenchyma.
- Accurate diagnosis and monitoring of diffuse liver diseases are crucial for patient management.
- Conventional imaging techniques have limitations in fully characterizing these diseases.
More Related Videos
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

